Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Hereditary Sensory and Autonomic Neuropathies × CA-4948 × Myeloid × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1 Myeloid 1

Conditions

Myelodysplastic Syndromes 2 Leukemia, Myeloid, Acute 2 Recurrence 1 Myeloproliferative Disorders 1 Hereditary Sensory and Autonomic Neuropathies 1

Interventions

venetoclax 1 ruxolitinib 1 parsaclisib 1 CA-4948 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04278768 2026-03-19

Dose Escalation/ Expansion Study of CA-4948 as Monotherapy in Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS)

Curis, Inc.

Phase 1/2 Suspended

MyeloidOther hematologic neoplasm

Myelodysplastic Syndromes, Hereditary Sensory and Autonomic Neuropathies, Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon ⚡